Preview Mode Links will not work in preview mode

This Week in Cardiology

Dec 15, 2023

FDA approves PFA, breakthrough in PAH, residual leaks after percutaneous LAAO, OAC in low to intermediate risk people are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I. FDA Approves PFA

FDA Approves First Pulsed Field Ablation System for AF


- ADVENT Trial


II. Pulmonary HTN

Positive Topline Data for Sotatercept in PAH: STELLAR


- Editorial on STELLAR

III. Peri-Device Leaks

- Greek Meta-analysis

IV. Intermediate Risk AF – Norwegian Study

- Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study AFNOR Study

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact